Weight gain in patients after therapy for hyperthyroidism

South African Medical Journal

Volumn 93, Issue 7, 2003, Pages 529-531

  Brunova, J ^a   Bruna, J ^a   Joubert, G ^a   Koning, M ^a  

^a UNIVERSITY OF THE FREE STATE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; CARBIMAZOLE; RADIOACTIVE IODINE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; FREE THYROXINE INDEX; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OBESITY; PREVALENCE; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; THYROID FUNCTION TEST; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; TOXIC GOITER; WEIGHT GAIN;

ANTITHYROID AGENTS; BODY MASS INDEX; CARBIMAZOLE; FEMALE; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; OBESITY; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; THYROID HORMONES; THYROIDECTOMY; THYROXINE; TIME FACTORS; WEIGHT GAIN;

EID: 0041903673     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Hoogwerf BJ, Nuttal FQ. Long term weight regulation in treated hyperthyroid and hypothyroid subjects. Am J Med 1984; 76: 963-970.
2. Abid M, Billington CJ, Nuttal FQ. Thyroid function and energy intake during weight gain following treatment of hyperthyroidism. J Am Coll Nutr 1999; 18: 189-193.
3. Brunova J, Mollentze W, Nel M, Joubert G. Radio-iodine therapy of hyperthyroid Graves' disease. S Afr Med J 1999; 89: 797-801.
4. Lustig RH. The neuroendocrinology of obesity. Endocrinol Metab Clin North Am 2001; 30: 765-785.
5. Garrow J. Epidemiology of Obesity in the UK. Obesity: The Report of the British Nutrition Foundation Task Force. 1st ed. Oxford: Blackwell Science, 1999: 23-36.
6. Van der Merwe M-T: The aetiology of obesity: A global and ethnic perspective. Journal of Endocrinology, Metabolism and Diabetes of South Africa 2001; 6: 84-89.
7. Dale J, Daykin J, Holder R, Sheppard MC, Franklyn JA. Weight gain following treatment of hyperthyroidism: a follow up study. Clin Endocrinol 2001; 55: 233-239.
8. De La Rosa RE, Hennessey JV, Tucci JR. A longitudinal study of changes in body mass index and total body composition after radioiodine treatment for thyrotoxicosis. Thyroid 1997; 7: 401-405.
9. Morley JE. Neuropeptide regulation of appetite and weight. Endocrinology Reviews 1987; 8: 256-287.
10. Tigas S, Idiculla J, Beckett G, Toft A. Is excessive weight gain after ablative treatment of hyperthyroidism due to inadequate thyroid hormone therapy? Thyroid 2000; 10: 1107-1111.
11. Pikney JH, Goodrick SJ, Kats J, et al. Leptin and the pituitary-thyroid axis: a comparative study in lean, obese, hypothyroid and hyperthyroid subjects. Clin Endocrinol 1998; 49: 583-588.
12. Yoshida T, Momotani N, Hayashi H, et al. Serum leptin concentrations in patients with thyroid disorders. Clin Endocrinol 1998; 48: 299-302.
13. Zimmerman-Belsing T, Dreyer M, Holst J, Feld-Rasmussen U. The relationship between the serum leptin concentration of thyrotoxic patients during treatment and their total fat mass is different from normal subjects. Clin Endocrinol 1998; 49: 589-595.